Vitamin D is far more than just the “sunshine vitamin” associated with bone health. It is a crucial fat-soluble secosteroid hormone that regulates calcium homeostasis, immune function, and cellular proliferation. While its role in preventing rickets and osteomalacia is well known, the specific implications of vitamin D deficiency for foot health are often overlooked in clinical practice. The feet, being complex biomechanical structures composed of 26 bones, numerous joints, ligaments, tendons, and nerves, are exquisitely sensitive to systemic metabolic imbalances. A growing body of evidence links vitamin D deficiency to a spectrum of pedal problems, including chronic heel pain, stress fractures, peripheral neuropathy, and impaired wound healing—each of which can dramatically reduce mobility and quality of life.

One of the most well-documented foot problems associated with low vitamin D is plantar fasciitis, a degenerative condition of the thick band of connective tissue running along the sole. Traditionally attributed to repetitive microtrauma and mechanical overload, plantar fasciitis is now increasingly viewed through a metabolic lens. Vitamin D receptors (VDRs) are present on fibroblasts and in the connective tissue fascia. When vitamin D is deficient, the anti-inflammatory and reparative functions of these receptors are compromised. Vitamin D modulates the production of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs), which are essential for extracellular matrix remodeling. In deficiency states, this balance is disrupted, leading to abnormal collagen deposition and a diminished capacity to resolve the microscopic tears that occur with each step. Consequently, patients with low serum 25-hydroxyvitamin D often present with bilateral, recalcitrant heel pain that responds poorly to conventional treatments like stretching or orthotics. Studies have shown that correcting the deficiency with high-dose vitamin D can significantly reduce visual analog scale (VAS) pain scores and improve the functional outcomes of the foot and ankle.

Beyond soft tissue disorders, vitamin D plays a fundamental role in bone mineralization and remodeling, making it critical for the metatarsals and phalanges. The foot absorbs high ground reaction forces—up to three times body weight during walking and even higher during running. Suboptimal vitamin D leads to secondary hyperparathyroidism, which increases bone resorption and reduces bone mineral density. This creates a predisposition to stress fractures, particularly in the metatarsals (the long bones of the midfoot). Unlike traumatic fractures, stress fractures from vitamin D deficiency develop insidiously, presenting as diffuse, activity-related pain that is often misdiagnosed as tendonitis. In athletes, military recruits, and older adults, vitamin D insufficiency has been directly correlated with an increased incidence of metatarsal and navicular stress fractures. Furthermore, once a fracture occurs, vitamin D is essential for fracture healing: it stimulates osteoblast activity and the synthesis of bone morphogenetic proteins. Deficient patients experience delayed union or even non-union of foot fractures, leading to prolonged immobilization, muscle atrophy, and chronic pain.

Another major category of foot pathology exacerbated by vitamin D deficiency is peripheral neuropathy. The feet are highly dependent on small nerve fibers for proprioception, temperature sensation, and pain perception. Vitamin D is neuroprotective: it regulates nerve growth factor (NGF) synthesis, modulates calcium channel activity in neurons, and reduces oxidative stress in Schwann cells. Deficiency correlates with an increased risk of both diabetic and non-diabetic peripheral neuropathy. Patients often describe burning, tingling, numbness, and “pins and needles” in the toes and soles. Importantly, vitamin D deficiency can also contribute to proximal myopathy—weakness of the calf and intrinsic foot muscles—which alters gait mechanics and increases fall risk. In older adults, this combination of impaired sensation and muscle weakness is a direct precursor to foot deformities such as hammertoes and Charcot neuroarthropathy in diabetic patients. Correcting vitamin D levels has been shown in clinical trials to improve neuropathic symptoms and reduce pain scores, independent of glycemic control.

Perhaps the most critical—and potentially limb-threatening—foot problem linked to vitamin D deficiency is impaired wound healing, particularly in the context of diabetic foot ulcers (DFUs). The foot is a common site for chronic wounds due to repetitive pressure, ischemia, and infection. Vitamin D accelerates cutaneous wound healing through multiple mechanisms: it enhances the production of cathelicidin (an antimicrobial peptide that prevents wound infection), promotes keratinocyte migration and proliferation, and suppresses the pro-inflammatory cytokines (such as TNF-? and IL-6) that perpetuate chronic inflammation. In deficiency states, wounds stall in the inflammatory phase and fail to transition to the proliferative phase characterized by granulation tissue formation and re-epithelialization. Numerous observational studies have found that patients with DFUs have significantly lower serum vitamin D levels compared to diabetic patients without ulcers. Moreover, low vitamin D is an independent predictor of major amputation: for every 10 ng/mL decrease in serum vitamin D, the risk of lower extremity amputation increases by approximately 40% in at-risk populations. Vitamin D repletion, combined with standard wound care, has been shown in randomized controlled trials to accelerate ulcer closure and reduce ulcer size more effectively than placebo.

The pathophysiology linking vitamin D to these diverse foot problems ultimately converges on systemic inflammation and immune dysregulation. Vitamin D acts as a negative regulator of the renin-angiotensin system and downregulates NF-?B, a master transcription factor for inflammatory mediators. In the foot, where even minor inflammation can compromise tight spaces like the tarsal tunnel or the plantar fascia, this anti-inflammatory action is critical. Furthermore, vitamin D improves skeletal muscle function by enhancing calcium uptake into the sarcoplasmic reticulum, which directly affects the gait cycle—deficiency leads to a waddling, unsteady gait that increases pressure points on the metatarsal heads and heels, predisposing to calluses, ulcers, and falls.

Despite this compelling evidence, vitamin D screening is not yet standard in podiatric or orthopedic foot clinics. Risk factors for deficiency include older age, dark skin pigmentation, obesity (vitamin D is sequestered in adipose tissue), chronic kidney disease, and geographic locations with limited sunlight. Serum 25-hydroxyvitamin D levels should ideally be maintained above 30 ng/mL, with many experts advocating for 40–60 ng/mL for optimal musculoskeletal and neurological function. Treatment involves either oral cholecalciferol (vitamin D3) at doses of 2000–5000 IU daily for maintenance or high-dose weekly regimens (50,000 IU) for severe deficiency, always co-administered with adequate calcium and magnesium.

Vitamin D is a foundational nutrient for foot health, influencing everything from the integrity of the plantar fascia and the strength of the metatarsals to the function of peripheral nerves and the healing of ulcers. The feet, as the body’s weight-bearing pillars, are unforgiving of metabolic deficiencies. Clinicians who treat foot problems—from podiatrists to primary care physicians—must broaden their differential diagnosis to include vitamin D deficiency, especially in patients with bilateral, persistent, or treatment-resistant conditions. Addressing this hidden deficiency is not only a safe and inexpensive intervention but can transform a patient from a cycle of chronic foot pain, falls, and ulcers to one of restored mobility and independence. For millions suffering from debilitating foot problems, vitamin D repletion may be the missing element in their care.